DAMP signaling in fungal infections and diseases

Frontiers in Immunology

Volumn 3, Issue SEP, 2012, Pages

  Cunha, Cristina ^a   Carvalho, Agostinho ^a,b   Esposito, Antonella ^c   Bistoni, Francesco ^a   Romani, Luigina ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF MINHO   (Portugal)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

DAMPs; Fungal diseases; Immunoregulation; Inflammation; PAMPs

Indexed keywords

EID: 84874239159     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00286     Document Type: Short Survey

References (44)

1. Antachopoulos, C., Walsh, T. J., and Roilides, E. (2007). Fungal infections in primary immunodeficiencies. Eur. J. Pediatr. 166, 1099-1117.
2. Bellocchio, S., Montagnoli, C., Bozza, S., Gaziano, R., Rossi, G., Mambula, S. S., Vecchi, A., Mantovani, A., Levitz, S. M., and Romani, L. (2004). The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J. Immunol. 172, 3059-3069.
3. Bianchi, M. E. (2007). DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 1-5.
4. Bozza, S., Zelante, T., Moretti, S., Bonifazi, P., Deluca, A., D'Angelo, C., Giovannini, G., Garlanda, C., Boon, L., Bistoni, F., Puccetti, P., Man-tovani, A., and Romani, L. (2008). Lack of Toll IL-1R8 exacerbates Th17 cell responses in fungal infection. J. Immunol. 180, 4022-4031.
5. Cooney, N. M., and Klein, B. S. (2008). Fungal adaptation to the mammalian host: it is a new world, after all. Curr. Opin. Microbiol. 11, 511-516.
6. Cunha, C., Aversa, F., Bistoni, G., Casagrande, A., Rodrigues, F., Romani, L., and Carvalho, A. (2011a). Immunogenetic profiling to predict risk of invasive fungal diseases: where are we now? Immunol. Invest. 40, 723-734.
7. Cunha, C., Giovannini, G., Pierini, A., Bell, A. S., Sorci, G., Riuzzi, F., Donato, R., Rodrigues, F., Velardi, A., Aversa, F., Romani, L., and Carvalho, A. (2011b). Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients. PLoS ONE 6, e27962. doi: 10.1371/journal.pone.0027962
8. Dangl,J.L., and Jones,J. D. (2001). Plant pathogens and integrated defence responses to infection. Nature 411, 826-833.
9. De Luca, A., Bozza, S., Zelante, T., Zagarella, S., D'Angelo, C., Perruccio, K., Vacca, C., Carvalho, A., Cunha, C., Aversa, F., and Romani, L. (2010). Non-hematopoietic cells contribute to protective tolerance to Aspergillus fumigatus via a TRIF pathway converging on IDO. Cell. Mol. Immunol. 7, 459-470.
10. De Luca, A., Montagnoli, C., Zelante, T., Bonifazi, P., Bozza, S., Moretti, S., D'Angelo, C., Vacca, C., Boon, L., Bistoni, F., Puccetti, P., Fallarino, F., and Romani, L. (2007). Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J. Immunol. 179, 5999-6008.
11. Donato, R. (2007). RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr. Mol. Med. 7, 711-724.
12. Gallucci, S., and Matzinger, P. (2001). Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13, 114-119.
13. Gottar, M., Gobert, V., Matskevich, A. A., Reichhart, J. M., Wang, C., Butt, T. M., Belvin, M., Hoffmann, J. A., and Ferrandon, D. (2006). Dual detection of fungal infections inDrosophila via recognition of glucans and sensing of virulence factors. Cell 127, 1425-1437.
14. Gross, O., Poeck, H., Bscheider, M., Dostert, C., Hannesschlager, N., Endres, S., Hartmann, G., Tardivel, A., Schweighoffer, E., Tybulewicz, V., Mocsai, A., Tschopp, J., and Ruland, J. (2009). Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459, 433-436.
15. Gupta, A. O., and Singh, N. (2011). Immune reconstitution syndrome and fungal infections. Curr. Opin. Infect. Dis. 24, 527-533.
16. Hise, A. G., Tomalka, J., Ganesan, S., Patel, K., Hall, B. A., Brown, G. D., and Fitzgerald, K. A. (2009). An essential role for the NLRP3 inflam-masome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 5, 487-497.
17. Holland, S. M., Deleo, F. R., Elloumi, H. Z., Hsu, A. P., Uzel, G., Brodsky, N., Freeman, A. F., Demidowich, A., Davis, J., Turner, M. L., Anderson, V. L., Darnell, D. N., Welch, P. A., Kuhns, D. B., Frucht, D. M., Malech, H. L., Gallin, J. I., Kobayashi, S. D., Whitney, A. R., Voyich, J. M., Musser, J. M., Woellner, C., Schaffer, A. A., Puck, J. M., and Grimbacher, B. (2007). STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357, 1608-1619.
18. Joly, S., Ma, N., Sadler, J. J., Soll, D. R., Cassel, S. L., and Sutterwala, F. S. (2009). Cutting edge: Candida albi-cans hyphae formation triggers activation of the Nlrp3 inflammasome. J. Immunol. 183, 3578-3581.
19. Joly, S., and Sutterwala, F. S. (2010). Fungal pathogen recognition by the NLRP3 inflammasome. Virulence 1, 276-280.
20. Kalea, A. Z., Reiniger, N., Yang, H., Arriero, M., Schmidt, A. M., and Hudson, B. I. (2009). Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene. FASEB J. 23, 1766- 1774.
21. Kariko, K., Ni, H., Capodici, J., Lamphier, M., and Weissman, D. (2004). mRNA is an endogenous ligand for Toll-like receptor 3. J. Biol. Chem. 279, 12542-12550.
22. Kumar, H., Kumagai, Y., Tsuchida, T., Koenig, P. A., Satoh, T., Guo, Z., Jang, M. H., Saitoh, T., Akira, S., and Kawai, T. (2009). Involvement of the NLRP3 inflammasome in innate and humoral adaptive immune responses to fungal beta-glucan. J. Immunol. 183, 8061-8067.
23. Lee, M. S., and Kim, Y. J. (2007). Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu. Rev. Biochem. 76, 447-480.
24. Lev-Sagie, A., Prus, D., Linhares, I. M., Lavy, Y., Ledger, W. J., and Witkin, S. S. (2009). Polymorphism in a gene coding for the inflammasome component NALP3 and recurrent vulvovaginal candidiasis in women with vulvar vestibulitis syndrome. Am. J. Obstet. Gynecol. 200, 303. e1-303.e6.
25. Mankan, A. K., Kubarenko, A., and Hornung, V. (2012). Immunology in clinic review series; focus on autoinflammatory diseases: inflammasomes: mechanisms of activation. Clin. Exp. Immunol. 167, 369-381.
26. Moretti, S., Bellocchio, S., Bonifazi, P., Bozza, S., Zelante, T., Bistoni, F., and Romani, L. (2008). The contribution of PARs to inflammation and immunity to fungi. Mucosal Immunol. 1, 156-168.
27. Perfect, J. R. (2012). The impact of the host on fungal infections. Am. J. Med. 125, S39-S51.
28. Piccinini, A. M., and Midwood, K. S. (2010). DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010, 672395.
29. Romani, L. (2011). Immunity to fungal infections. Nat. Rev. Immunol. 11, 275-288.
30. Romani, L., and Puccetti, P. (2007). Controlling pathogenic inflammation to fungi. Expert Rev. Anti Infect. Ther. 5, 1007-1017.
31. Said-Sadier, N., Padilla, E., Langsley, G., and Ojcius, D. M. (2010). Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS production and the Syk tyrosine kinase. PLoS ONE 5, e10008. doi: 10.1371/journal.pone.0010008
32. Santamaria, R., Rizzetto, L., Bromley, M., Zelante, T., Lee, W., Cavalieri, D., Romani, L., Miller, B., Gut, I., Santos, M., Pierre, P., Bowyer, P., and Kapushesky, M. (2011). Systems biology of infectious diseases: a focus on fungal infections. Immunobiology 216, 1212-1227.
33. Schmidt, A. M., Yan, S. D., Yan, S. F., and Stern, D. M. (2001). The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 108, 949-955.
34. Shpacovitch, V., Feld, M., Bunnett, N. W., and Steinhoff, M. (2007). Protease-activated receptors: novel PARtners in innate immunity. Trends Immunol. 28, 541-550.
35. Sitkovsky, M. V., and Ohta, A. (2005). The 'danger' sensors that STOP the immune response: the A2 adeno-sine receptors? Trends Immunol. 26, 299-304.
36. Sorci, G., Giovannini, G., Riuzzi, F., Bonifazi, P., Zelante, T., Zagarella, S., Bistoni, F., Donato, R., and Romani, L. (2011). The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation. PLoS Pathog. 7, e1001315. doi: 10.1371/journal.ppat. 1001315
37. Sparvero, L. J., Asafu-Adjei, D., Kang, R., Tang, D., Amin, N., Im, J., Rutledge, R., Lin, B., Amoscato, A. A., Zeh, H. J., and Lotze, M. T. (2009). RAGE (receptor for advanced glycation end-products), RAGE ligands, and their role in cancer and inflammation. J. Transl. Med. 7, 17.
38. Srikrishna, G., and Freeze, H. H. (2009). Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 11, 615-628.
39. Tomalka, J., Ganesan, S., Azodi, E., Patel, K., Majmudar, P., Hall, B. A., Fitzgerald, K. A., and Hise, A. G. (2011). A novel role for the NLRC4 inflam-masome in mucosal defenses against the fungal pathogen Candida albi-cans. PLoS Pathog. 7, e1002379. doi: 10.1371/journal.ppat.1002379
40. Trinchieri, G., and Sher, A. (2007). Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 7, 179-190.
41. Van de Veerdonk, F. L., Joosten, L. A., Shaw, P. J., Smeekens, S. P., Malireddi, R. K., van der Meer, J. W., Kullberg, B. J., Netea, M. G., and Kanneganti, T. D. (2011). The inflam-masome drives protective Th1 and Th17 cellular responses in disseminated candidiasis. Eur. J. Immunol. 41, 2260-2268.
42. Vonk, A. G., Netea, M. G., van Krieken, J. H., Iwakura, Y., van der Meer, J. W., and Kullberg, B. J. (2006). Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis. J. Infect. Dis. 193, 1419-1426.
43. Yano, J., Noverr, M. C., and Fidel, P. L. Jr. (2012). Cytokines in the host response to Candida vaginitis: identifying a role for non-classical immune mediators, S100 alarmins. Cytokine 58, 118-128.
44. Zelante, T., Iannitti, R. G., De Luca, A., Arroyo, J., Blanco, N., Servillo, G., Sanglard, D., Reichard, U., Palmer, G. E., Latge, J. P., Puccetti, P., and Romani, L. (2012). Sensing of mammalian IL-17A regulates fungal adaptation and virulence. Nat. Commun. 3, 683.